citation_journal,link,PMID
"Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, et al. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second‐line anti‐tuberculosis drugs.  International Journal of Tuberculosis and Lung Disease 2012;16(1):104‐9. CENTRAL    PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/22236854,22236854
"Kambli P, Ajbani K, Nikam C, Khillari A, Shetty A, Udwadia Z, et al. Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.  The International Journal of Tuberculosis and Lung Disease 2015;19(10):1227‐9.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/26459538,26459538
"Tomasicchio M, Theron G, Pietersen E, Streicher E, Stanley‐Josephs D, Helden P, et al. The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug‐resistant TB detection when performed on sputum and culture isolates.  Scientific Reports 2016;6:17850. [DOI: 10.1038/srep17850] CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/26860462,26860462
"Kontsevaya I, Ignatyeva O, Nikolayevskyy V, Balabanova Y, Kovalyov A, Kritsky A, et al. Diagnostic accuracy of the genotype MTBDRsl assay for rapid diagnosis of extensively drug‐resistant tuberculosis in HIV‐coinfected patients.  Journal of Clinical Microbiology 2013;51(1):243‐8.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23152552,23152552
"Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, et al. Performance comparison of three rapid tests for the diagnosis of drug‐resistant tuberculosis.  PLoS One 2015;10(8):e0136861.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/26322781,26322781
"Ferro B, García P, Nieto LM, Soolingen D. Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.  Journal of Clinical Microbiology 2013;51(7):2220‐4.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23658272,23658272
"Barnard M, Warren R, Gey Van Pittius N, Helden P, Bosman M, Streicher E, et al. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug‐resistant tuberculosis in a high‐throughput diagnostic laboratory.  American Journal of Respiratory and Critical Care Medicine 2012;186(12):1298‐305.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23087027,23087027
"Ingen J, Simons S, Zwaan R, Laan T, Kamst‐van Agterveld M, Boeree MJ, et al. Comparative study on genotypic and phenotypic second‐line drug resistance testing of Mycobacterium tuberculosis complex isolates.  Journal of Clinical Microbiology 2010;48(8):2749–53.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/20554815,20554815
"Ignatyeva O, Kontsevaya I, Kovalyov A, Balabanova Y, Nikolayevskyy V, Toit K, et al. Detection of resistance to second‐line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.  Journal of Clinical Microbiology 2012;50(5):1593‐7.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/22378910,22378910
"Huang WL, Chi TL, Wu MH, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second‐line and ethambutol drug resistance among patients infected with multidrug‐resistant Mycobacterium tuberculosis .  Journal of Clinical Microbiology 2011;49(7):2502–8.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/21562102,21562102
"Kontsevaya I, Mironova S, Nikolayevskyy V, Balabanova Y, Mitchell S, Drobniewski F. Evaluation of two molecular assays for rapid detection of Mycobacterium tuberculosis resistance to fluoroquinolones in high‐tuberculosis and ‐multidrug‐resistance settings.  Journal of Clinical Microbiology 2011;49(8):2832–7.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/21632897,21632897
"Hillemann D, Rüsch‐Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin‐capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.  Journal of Clinical Microbiology 2009;47(6):1767–72.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/19386845,19386845
"Miotto P, Cabibbe AM, Mantegani P, Borroni E, Fattorini L, Tortoli E, et al. GenoType MTBDRsl performance on clinical samples with diverse genetic background.  European Respiratory Journal 2012;40(3):690‐8.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/22267773,22267773
"Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, et al. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.  Tuberculosis (Edinb) 2015;95(2):137‐41.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/25522842,25522842
"Simons SO, Laan T, Zwaan R, Kamst M, Ingen J, Dekhuijzen PN, et al. Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.  The International Journal of Tuberculosis and Lung Disease 2015;19(7):828‐33.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/26056110,26056110
"Ajbani K, Nikam C, Kazi M, Gray C, Boehme C, Balan K, et al. Evaluation of GenoType MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.  PLoS One 2012;7(11):e49433.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23166667,23166667
"Kiet VS, Lan NT, An DD, Dung NH, Hoa DV, Vinh Chau N, et al. Evaluation of the MTBDRsl test for detection of second‐line‐drug resistance in Mycobacterium tuberculosis.  Journal of Clinical Microbiology 2010;48(8):2934–9.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/20573868,20573868
"Lacoma A, García‐Sierra N, Prat C, Maldonado J, Ruiz‐Manzano J, Haba L, et al. GenoType MTBDRsl for molecular detection of second‐line‐drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.  Journal of Clinical Microbiology 2012;50(1):30–6.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/22075597,22075597
"Chikamatsu K, Aono A, Yamada H, Mitarai S. Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinolone, aminoglycoside, and ethambutol.  Kekkaku [Tuberculosis] 2012;87(10):641–7.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23214120,23214120
"Surcouf C, Heng S, Pierre‐Audigier C, Cadet‐Daniel V, Namouchi A, Murray A, et al. Molecular detection of fluoroquinolone‐resistance in multi‐drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.  BMC Infectious Diseases 2011;11:255.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/21955640,21955640
"Tukvadze N, Bablishvili N, Apsindzelashvili R, Blumberg HM, Kempker RR. Performance of the MTBDRsl assay in Georgia.  The International Journal of Tuberculosis and Lung Disease 2014;18(2):233‐9.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/24429319,24429319
"Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second‐line drugs and ethambutol in multidrug‐resistant Mycobacterium tuberculosis complex isolates.  Journal of Clinical Microbiology 2010;48(5):1683–9.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/20335420,20335420
"López‐Roa P, Ruiz‐Serrano MJ, Alcalá L, García‐Escribano Ráez N, García de Viedma D, Bouza E. Susceptibility testing to second‐line drugs and ethambutol by GenoType MTBDRsl and Bactec MGIT 960 comparing with agar proportion method.  Tuberculosis 2012;92(5):417–21.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/22698869,22698869
"Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, et al. Diagnostic performance of the new version (v2. 0) of GenoType MTBDRsl assay for detection of resistance to fluoroquinolones and second‐line injectable drugs: a multicenter study.  Journal of Clinical Microbiology 2015;53(9):2961‐9.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/26179309,26179309
"Jin J, Shen Y, Fan X, Diao N, Wang F, Wang S, et al. Underestimation of the resistance of Mycobacterium tuberculosis to second‐line drugs by the new GenoType MTBDRsl test.  The Journal of Molecular Diagnostics 2013;15(1):44–50.  CENTRAL   PubMed     Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23159109,23159109
